SATURDAY, DECEMBER 16, 2017

MMRGlobal announces patent valuation increase

MMRGlobal, Inc., a provider of online personal health records, announced on Monday that an investment banking and strategic advisory firm increased the valuation of a recently issued MMR patent by $200 million. Read More »

Afghanistan signs $100 million grant with World Bank for better health outcomes

The government of Afghanistan signed a $100 million grant with the World Bank on Monday to finance the Afghanistan System Enhancement for Health Action in Transition program. Read More »

Thomas F. Schaible appointed project leader of Coronado Biosciences IBD efforts

Coronado Biosciences, Inc., announced on Tuesday Thomas F. Schaible joined the company as project leader for the research and development of Trichuris suis ova treatments for inflammatory bowel disease. Read More »

UNAIDS commends Rwanda on successes against HIV prevalence

UNAIDS Executive Director Michel SidibĂ© recently congratulated the Rwandan government on its HIV response progress and movement towards reaching its global HIV goals. Read More »

PHE announces new additions to U.K. vaccination program

The United Kingdom Department of Health, Public Health England and the National Health Service England announced multiple changes on Tuesday to the current vaccination schedule including the introduction of three new vaccines. Read More »

TSRI announces new agreement with Janssen to focus on flu virus project

The Scripps Research Institute, a La Jolla, California-based independent biomedical research organization, announced a new five-year research agreement on Tuesday with Janssen Pharmaceuticals, Inc., which will initially focus on influenza research. Read More »

TSRI conducts successful trial of vaccine which counters heroin relapse

Scientists at The Scripps Research Institute reported on Tuesday the successful trial of a vaccine that blocks the blood-brain barrier for heroin, countering relapse. Read More »

Malaria, TB and HIV vaccine research collaboration receives $2.9 million grant

Aeras, the University of Oxford and Okairos announced on Tuesday that they have received a $2.9 million grant to support their collaboration in the development of vaccines treating TB, HIV and malaria. Read More »

U.N. secretary-general highlights importance of private sector in maternal health

Ban Ki-Moon Read More »

Lesotho cooperates with Global Fund to expand TB and HIV programs

The Global Fund to Fight AIDS, Tuberculosis and Malaria recently announced the signing of two grant agreements worth $17 million on Wednesday with Lesotho to expand the country's treatment of HIV and multi-drug-resistant TB. Read More »

Medicago produces vaccine candidate for H7N9 virus

H7N9 Virus Read More »

Rotary International commends U.S. on contributions to end polio

Rotary International recognized five members from the U.S. Polio Eradication Champions on Wednesday at the Capitol Building in Washington D.C. for their contributions to end polio. Read More »

Qasim: We must reach all Somali children with vaccines

The Somalian government is committed to reaching all Somalian children with a new pentavalent vaccine to break the cycle of unnecessary deaths, UNICEF said on Tuesday. Read More »

Takeda acquires Inviragen in $250 million deal

Takeda Pharmaceutical Company Limited, a Japan-based research pharmaceutical company, announced on Wednesday that it will acquire Inviragen, Inc., a Colorado-based biopharmaceutical company, as part of a $250 million deal. Read More »

Research shows potential insights for Ebola therapies

Ebola Read More »

HIV vaccine trial shines light on potential virus vulnerabilities

HIV Read More »

New HPV vaccine deals will ensure millions are protected

A record low price for human papillomavirus vaccines will allow millions of girls in developing countries to be protected against deadly cervical cancer, the GAVI Alliance said on Thursday. Read More »

Redx Pharma subsidiary will take over part of AstraZeneca site in U.K.

Redx Anti-Infectives, a subsidiary of Liverpool-based Redx Pharma, announced its launch on Wednesday at AstraZeneca's downsized research and development site in Alderley Park in Cheshire County, U.K. Read More »

Study shows good results for anti HIV, tuberculosis homeopathic

Tuberculosis Read More »

New T cell discovery shows promise for herpes vaccine

Fred Hutchinson Cancer Research Center and University of Washington scientists announced on Wednesday that they discovered the cells responsible for suppressing herpes symptoms, which may provide a viable vaccine. Read More »